35 bioequivalence tests approved in July

Published: 2012-08-09 06:57:00
Updated: 2012-08-09 06:57:00
The Korea Food and Drug Administration confirmed recently that it approved bioequivalence tests for a total of 35 drugs filed by of 20 pharmaceutical firms in July.

By company, LG Life Sciences topped the list with 9 generics – Atacand (candesartan), Diovan (valsartan), Olmetec (olmesartan), C...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.